New registry aims to learn from Real-World retreatment of gynecologic cancers
NCT ID NCT07667192
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This observational registry is gathering data from 500 adults whose gynecologic cancer has returned after prior radiation therapy. Doctors are using reirradiation or other ablative strategies as part of standard care, and the registry will track how well these treatments control the cancer, side effects, and quality of life. The goal is to learn from real-world practice to guide future treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY PERITONEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affidea NU-MED Center of Oncological Diagnostics and Therapy
RECRUITINGZamość, Lublin Voivodeship, 22-400, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a custom vaccine train the body to fight ovarian cancer?
- Can an immunotherapy-angiogenesis combo outshine standard chemo for advanced cervical cancer?
- Can a daily pill keep BRCA-Linked ovarian cancer at bay?
- New drug cocktail aims to shrink recurrent ovarian tumors
- New drug combo aims to stall ovarian cancer in patients without common DNA repair flaw
- New drug combo aims to outsmart recurrent ovarian cancer